Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer management.

Abstract

Ubiquitination is a critical biological process in post-translational modification of proteins and involves multiple signaling pathways in protein metabolism, apoptosis, DNA damage, cell-cycle progression, and cancer development. Deubiquitinase, a specific enzyme that regulates the ubiquitination process, is also thought to be closely associated with the development and progression of various cancers. In this article, we systematically review the emerging role of the deubiquitinase ubiquitin-specific peptidase 11 (USP11) in many cancer-related pathways. The results show that USP11 promotes or inhibits the progression and chemoresistance of different cancers, including colorectal, breast, ovarian, and hepatocellular carcinomas, via deubiquitinating several critical proteins of cancer-related pathways. We initially summarize the role of USP11 in different cancers and further discuss the possibility of USP11 as a therapeutic strategy.

• Authors: Yihao Liao, Diansheng Zhou, Pu Wang, Mengyue Yang, Ning Jiang
• Journal: Cell death discovery (Cell Death Discov) Vol. 8 Issue 1 Pg. 292 (Jun 17 2022) ISSN: 2058-7716 [Print] United States
• PMID: 35715413 (Publication Type: Journal Article, Review)
• Copyright: © 2022. The Author(s).